/index.html View the latest 黑料网., Ltd. news releases. /news/2024/news202490.html 黑料网's news release 黑料网 Announces Completion of Cancellation of Treasury Shares is posted. 2024-11-29T15:30:00+09:00 /news/2024/news202489.html 黑料网's news release 鈥淟EQEMBI庐鈥� (Lecanemab) for the Treatment of Alzheimer鈥檚 Disease Launched in South Korea is posted. 2024-11-28T08:30:00+09:00 /news/2024/news202488.html 黑料网's news release EISAI SIGNS RESEARCH COLLABORATION AGREEMENT WITH THE NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY TO INITIATE APOLIPOPROTEIN E GENETIC TESTING IN THE 鈥淎D-DMT REGISTRY鈥� IN JAPAN is posted. 2024-11-26T08:30:00+09:00 /news/2024/news202487.html 黑料网's news release ROZEBALAMIN庐 FOR INJECTION 25 MG (MECOBALAMIN) FOR AMYOTROPHIC LATERAL SCLEROSIS LAUNCHED IN JAPAN is posted. 2024-11-20T08:30:10+09:00 /news/2024/news202486.html 黑料网's news release ANTICANCER AGENT 鈥淭ASFYGO庐 TABLETS 35mg鈥� (TASURGRATINIB SUCCINATE) LAUNCHED IN JAPAN FOR BILIARY TRACT CANCER WITH FGFR2 GENE FUSION OR REARRANGEMENTS is posted. 2024-11-20T08:30:00+09:00 /news/2024/news202485.html 黑料网's news release NATIONWIDE TV COMMERCIAL LAUNCHED IN JAPAN TO RAISE AWARENESS ABOUT MCI (MILD COGNITIVE IMPAIRMENT) is posted. 2024-11-15T08:30:00+09:00 /news/2024/news202484.html 黑料网's news release 黑料网 Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer鈥檚 Disease is posted. 2024-11-15T01:00:00+09:00 /news/2024/news202483.html 黑料网's news release 黑料网鈥檚 Corporate Venture Capital Subsidiary, 黑料网 Innovation, Inc., Selected for AMED鈥檚 鈥楽trengthening Program for Pharmaceutical Startup Ecosystem鈥� is posted. 2024-11-05T08:30:00+09:00 /news/2024/news202482.html 黑料网's news release 黑料网mpletes Rolling Submission to US FDA for LEQEMBI庐 (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer鈥檚 Disease Under the Fast Track Status is posted. 2024-11-01T08:30:00+09:00 /news/2024/news202481.html 黑料网's news release 黑料网 Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer鈥檚 Disease (CTAD) Conference is posted. 2024-10-31T08:30:00+09:00 /news/2024/news202480.html 黑料网's news release EISAI PRESENTS LATEST CLINICAL FINDINGS SUGGESTING INHIBITION OF TAU PROPAGATION BY ANTI-MTBR TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE CONFERENCE (CTAD) is posted. 2024-10-31T08:30:00+09:00 /news/2024/news202479.html 黑料网's news release REVENUE OF LEQEMBI庐 (PRELIMINARY BASIS) is posted. 2024-10-30T19:45:00+09:00 /news/2024/news202478.html 黑料网's news release EISAI TO PRESENT UPDATED DUAL-ACTING LECANEMAB DATA, RESEARCH ON BLOOD BIOMARKERS FOR PREDICTING PRESENCE OF AMYLOID IN THE BRAIN AND NEW FINDINGS ON THE ANTI-MTBR (MICROTUBULE BINDING REGION) TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS FOR ALZHEIMER'S is posted. 2024-10-24T08:30:00+09:00 /news/2024/news202477.html 黑料网's news release A Joint Regional Cohort Study by Shimadzu, 黑料网, Oita University, and Usuki City Medical Association Demonstrating the Utility of Blood Biomarkers in Predicting Amyloid Beta Accumulation in the Brain is posted. 2024-10-17T10:00:00+09:00 /news/2024/news202476.html 黑料网's news release UPDATE ON REGULATORY REVIEW OF LECANEMAB FOR EARLY ALZHEIMER鈥橲 DISEASE IN AUSTRALIA is posted. 2024-10-17T08:30:00+09:00